Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...

Inflammatory Bowel Disease IV: Pharmacological Management

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...

COPD: Management Using Bronchodilators and Corticosteroids

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...

Drugs for Treatment of Ulcerative Colitis in IBD

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Recent Progress on Selenium Nanoparticles: Synthesis and Neuroprotective Effects for the Treatment of Alzheimer's Disease.

Molecular neurobiology·2026

Same author

DNA methylation signatures from peripheral blood revealed epigenetic alterations in Fanconi anemia.

Human genetics·2026

Same author

Communication when bone and joint infection in children is suspected : a qualitative study of patients, families, and health professionals.

Bone & joint open·2026

Same author

Decanoic Acid Treatment Alleviates Non-cell Autonomous Transfer of HD Pathology by Secretome of Mutant Huntingtin Expressing Cells.

Neurochemical research·2026

Same author

A Rare Variant in RPS26 Gene Causing Variable Phenotype of Diamond-Blackfan Anemia Type 10 (DBA10) in an Indian Family.

Indian journal of pediatrics·2025

Same author

Real-World Data on the Practice of Chemoradiation with Select Cohort Consolidation Chemotherapy in High-Risk Locally Advanced Rectal Cancers (SOLAR study).

South Asian journal of cancer·2025

Search research articles

Related Experiment Videos

Corticosteroids for multiple sclerosis: I. Application for treating exacerbations.

Elliot M Frohman¹, Anjali Shah, Eric Eggenberger

¹Department of Neurology, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75235, USA. elliot.frohman@utsouthwestern.edu

Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics

|October 9, 2007

Summary

This summary is machine-generated.

This review explores anti-inflammatory treatments for multiple sclerosis (MS) exacerbations, focusing on corticosteroids and adrenocorticotropic hormone. It aims to clarify their use in clinical practice for managing MS attacks.

Related Experiment Videos

Area of Science:

Neurology
Immunology

Background:

Multiple sclerosis (MS) is an inflammatory demyelinating disease with relapsing-remitting and progressive phases.
Exacerbations involve acute neurological dysfunction due to central nervous system inflammation.

Purpose of the Study:

To review the pharmacology of anti-inflammatory agents used for MS exacerbations.
To provide practical guidance for using corticosteroids and adrenocorticotropic hormone in clinical settings.

Main Methods:

Literature review of pharmacological properties of anti-inflammatory agents.
Analysis of current clinical practices and expert opinions.

Main Results:

Corticosteroids and adrenocorticotropic hormone are established treatments for MS exacerbations.
Clinical application is largely based on expert opinion and anecdotal evidence, highlighting a gap between scientific rationale and practice.

Conclusions:

Understanding the pharmacology of these agents can improve their efficacy in mitigating MS attacks.
Standardized, evidence-based guidelines are needed to optimize the treatment of MS exacerbations.